Status:
RECRUITING
Acoustic Stimulation During Restricted Sleep After Sleep Deprivation
Lead Sponsor:
Walter Reed Army Institute of Research (WRAIR)
Collaborating Sponsors:
Philips Healthcare
Conditions:
Sleep Deprivation
Sleep Restriction
Eligibility:
All Genders
18-39 years
Phase:
NA
Brief Summary
The purpose of this study is to determine if brief sounds or tones presented within a restricted period of recovery sleep after a period of sleep deprivation will enhance restorative properties and im...
Eligibility Criteria
Inclusion
- Healthy men and non-pregnant, non-lactating women 18 to 39 years of age (inclusive)
- Must demonstrate adequate comprehension of the protocol, by achieving a score of at least 80% correct on a short multiple-choice quiz. Individuals who fail to achieve a passing score on the initial quiz will be given one opportunity to retest after a review of protocol information. Individuals who fail the comprehension assessment for the second time will be disqualified.
Exclusion
- You must have learned English as your first language
- You must have a body mass index (BMI) below 30 (this is a mathematical calculation of your height and weight)
- You must not have current or a history of sleeping problems (for example, insomnia or sleep apnea), or symptoms that indicate a potential sleep disorder
- You must get an average of 6-9 hours of sleep per night and maintain a normal sleep/wake schedule
- You must not drink excessive amounts of caffeine, alcohol, or smoke cigarettes regularly
- You must not be on certain medications (determined on a case by case basis)
- You must test negative for illicit drugs
- Women must not be pregnant or nursing
- You must not be participating in another ongoing clinical trial
- You must have a social security number or tax identification number in order to be paid for screening and participation in the study
- You cannot have a history of the following conditions: Cardiovascular disease, a neurologic disorder, pulmonary disease requiring inhaler use, kidney disease or kidney abnormalities, liver disease of liver abnormalities, a history of psychiatric disorder requiring hospitalization or medication within the last two years or for a continuous period of more than 6 months in the last ten years
Key Trial Info
Start Date :
March 14 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT05309473
Start Date
March 14 2022
End Date
October 1 2026
Last Update
April 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Walter Reed Army Institute of Research
Silver Spring, Maryland, United States, 20910